Streamlining Medication Costs with AI, Pharmacists, and Policy

Inefficiency Insights #38

What’s the problem?

In the inpatient setting, physicians face the cumbersome and time-consuming task of determining the most cost-effective anticoagulation medication for patients with newly discovered pulmonary embolism or deep vein thrombosis.

Become a Huddle+ member below for full access to a detailed problem description, root cause and impact analyses, and three solutions to the problem.

Subscribe to Huddle+ to read the rest.

Become a paying subscriber of Huddle+ to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In

A subscription gets you:
2 months free with annual subscription
Weekly Inefficiency Insights newsletter
Monthly Huddle #Trends reports
Huddle University, an educational platform